Mira Chaurushiya
Managing Director at Westlake Village BioPartners®
San Francisco, California
Overview
Work Experience
Managing Director
2022 - Current
Westlake Village BioPartners is venture capital firm focused on incubating and building life sciences companies.
Fellow, Class 21
2016
Co-investment VC firm supporting the mission of the Kauffman Fellows
Board Of Directors
2016 - 2022
Biotech Connection is a non-profit that provides career development and experience based learning activities for life sciences PhD candidates and postdoctoral fellows, in partnership with local biotech companies.
Biotech Connection provides research, diligence, and scientific insight for biotechnology clients.
Partner
2020 - 2021
Principal
2018 - 2020
Associate / Senior Associate
2016 - 2018
5AM Ventures is a venture capital firm that aims to finance seed and early-stage life sciences companies.
Board Observer
2020 - 2021
Director Board Of Directors
2018 - 2020
Novome Biotechnologies is a biotechnology company focused on engineering defined activities into the human.
Raised $83,060,623.00 from 5AM Ventures, Alexandria Venture Investments, Alta Partners, Tencent, DCVC Bio, Touchdown Ventures, University of Minnesota and Navian Capital.
Board Observer
2019 - 2021
TMRW Life Sciences provides an integrated platform for automated, software-guided cryospecimen management.
Raised $181,672,940.00 from 5AM Ventures, FIOS Venture Holdings, What If Ventures, Transformation Capital, LSI (Life Science Innovations Fund), Google Ventures, Casdin Capital and Amy Schumer.
Board Of Directors
2019 - 2021
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Raised $230,000,000.00 from Acuta Capital Partners, Venrock Healthcare Capital Partners, Commodore Capital, Rock Springs Capital, Logos Capital, Fairmount Funds Management and Woodline Partners.
Board Observer
2018 - 2021
Escient Pharmaceuticals is a privately-held biotechnology company focusing on the advancement of G Protein-Coupled Receptor targeted drugs.
Raised $237,500,000.00 from PFM Health Sciences, Sanofi Ventures, OUP (Osage University Partners), The Eleven Fund, Cowen Healthcare Investments, Redmile Group, 5AM Ventures, Forge Life Science Partners, Altitude Life Science Ventures and New Enterprise Associates.
Board Of Directors
2016 - 2021
Acquired by BioNano in Nov 2022
Purigen Biosystems' innovative products offer a truly transformative automated solution for DNA and RNA purification.
Raised $93,086,615.00 from Cota Capital, Agilent Technologies, 5AM Ventures and Roche Venture Fund.
Board Observer
2016 - 2021
BlueLight Therapeutics uses a proprietary structure-based platform to discover small molecules against difficult-to-drug targets.
Raised $46,551,509.00 from 5AM Ventures, Roche Venture Fund, Pfizer Venture Investments and Alexandria Venture Investments.